Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Particle Therapy Market Analysis and Forecasts, 2023-2033 : Revolutionizing Cancer Treatment, Particle Therapy's Rise in External Beam Radiotherapy


DUBLIN, March 27, 2024 /PRNewswire/ -- The "Global Particle Therapy Market: Focus on Products and Services, Application, Cancer Type, Type, System, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge. Additionally, the report discusses the factors driving market growth, challenges and potential risks are addressed, aiding stakeholders in making informed decisions.

Particle therapy, a specialized form of external beam radiotherapy utilizing energetic protons, neutrons, or heavy positive ions, is gaining traction in cancer treatment. Market expansion is primarily propelled by factors such as the increasing incidence of cancer, heightened adoption of particle therapy in clinical research, continual technological advancements, and the proliferation of particle therapy centres worldwide.

The global particle therapy market is experiencing a remarkable upswing, emerging as a transformative force in the field of cancer treatment. The demand for advanced and precise therapeutic solutions has fueled the growth of particle therapy, positioning it as a game-changer in the global healthcare landscape.

With a blend of quantitative and qualitative analysis, this report serves as a valuable resource for industry participants, investors, and decision-makers seeking to understand the dynamics of the global particle therapy market.

Key Questions Answered in this Report:

Market Overview:

Segmentation and Market Share:

Competitive Landscape:

Forecast and Outlook:

Key Market Players:

Key Topics Covered:

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Company)
1.4 Regulatory Landscape
1.5 Impact Analysis for Key Global Events - COVID-19
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities

2 Application
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Particle Therapy Market (by Application)
2.3.1 Treatment
2.3.2 Research
2.4 Global Particle Therapy Market (by Cancer Type)
2.4.1 Paediatric Cancer
2.4.2 Lung Cancer
2.4.3 Breast Cancer
2.4.4 Head and Neck Cancer
2.4.5 Other Cancers

3 Products
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Particle Therapy Market (by Products and Services)
3.3.1 Products
3.3.2 Services
3.4 Global Particle Therapy Market (by Type)
3.4.1 Proton Therapy
3.4.2 Heavy-Ion Therapy
3.5 Global Particle Therapy Market (By System)
3.5.1 Multi-room Systems
3.5.2 Single-room Systems

4 Regions
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 U.S. Particle Therapy Market by Application
4.3.8 Canada
4.3.9 Canada Particle Therapy Market by Application
4.4 Europe
4.5 Asia Pacific
4.6 Rest-of-the-World

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.2.1 Advanced Oncotherapy Plc.
5.2.1.1 Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.1.7 Market Share
5.2.2 Biosig Technologies, Inc.
5.2.3 Danfysik A/S
5.2.4 Elekta
5.2.5 Hitachi Ltd.
5.2.6 IBA
5.2.7 Mevion Medical Systems
5.2.8 Panacea Medical Technologies
5.2.9 Optivus Proton Therapy, Inc.
5.2.10 P-Cure
5.2.11 ProTom International
5.2.12 Provision Healthcare
5.2.13 Siemens Healthcare GmbH (Variant Medical Systems, Inc.)
5.2.14 Sumitomo Heavy Industries, Ltd.
5.2.15 Toshiba Medical Systems Corp.

6 Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/bqvlc9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

10 mai 2024
Sky Harbour Group Corporation ("SHG" or the "Company"), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its First Quarter 2024 financial...

10 mai 2024
Victoria Gold Corp. ("Victoria" or the "Company") held its Annual General Meeting (the "Meeting") earlier today, May 10, 2024, in Vancouver, British Columbia. Shareholders voted in favour of all items proposed by the board of directors and...

10 mai 2024
Canada Jetlines Operations Ltd. (Cboe CA:CJET) ("Canada Jetlines" or the "Company"), one of Canada's leading leisure airlines, today reported financial results for the first quarter ended March 31, 2024. All financial figures are...

10 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

10 mai 2024
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company's Form 10-Q can...

10 mai 2024
Striking new work from the acclaimed visual artist behind the Covid flags on the Mall opened to the public today at Freedom Plaza in Washington, D.C. Suzanne Brennan Firstenberg launched her latest work "alienable right to life," at a moving opening...



News published on and distributed by: